FAWZI ABU ROUS

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology LANSING, MI NPI 1992226575

General Payments — all program years on this page

$11,099.01

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $8,965.51 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $183.334
2021 $64.991
2023 $1,885.183
2024 $8,965.5114

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086238808 Bayer Healthcare Pharmaceuticals Inc. $1,140.00 10/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089390758 Daiichi Sankyo Inc. $1,712.50 07/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089390760 Daiichi Sankyo Inc. $342.50 09/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101486636 E.R. Squibb & Sons, L.L.C. $1,920.00 09/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101486711 E.R. Squibb & Sons, L.L.C. $93.52 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118264129 Boehringer Ingelheim Pharmaceuticals, Inc. $43.48 12/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118264131 Boehringer Ingelheim Pharmaceuticals, Inc. $202.85 12/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118264133 Boehringer Ingelheim Pharmaceuticals, Inc. $450.18 11/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1132065315 PFIZER INC. $1,440.00 07/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1133011169 Genentech USA, Inc. $3.26 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133011173 Genentech USA, Inc. $46.49 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133011177 Genentech USA, Inc. $1,425.00 11/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133011181 Genentech USA, Inc. $82.97 11/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133011184 Genentech, Inc. $62.76 09/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.